Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Diamine oxidase (DAO), also known as amine oxidase, copper-containing 1 (AOC1) or histaminase, is an enzyme primarily responsible for the metabolism and inactivation of histamine and other polyamines such as putrescine and spermidine. DAO plays a crucial role in maintaining healthy histamine levels in the body by breaking down excess histamine, particularly that which is ingested through food. Deficiency or reduced activity of DAO leads to accumulation of dietary/exogenous histamine causing symptoms collectively termed "histamine intolerance" or "food/enteral histaminosis".
Catalyzes the oxidative deamination of diamines, including histamine, converting them into their corresponding aldehydes while releasing ammonia and hydrogen peroxide.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diamine Oxidase (None).